We evaluated the differences within various ethnic groups diagnosed with head and neck cancer in the USA with a specific focus on the clinical outcomes of patients of Hispanic ethnicity. We used the Surveillance, Epidemiology, and End Results (SEER) database to examine the clinical outcomes of patients with head and neck cancer by ethnicity, region of origin, place of birth, treatment modality, primary location, age, gender, and SEER tumor stage. For all patients, African American race conferred the worst prognosis for head and neck cancer (1.41; CI 1.361–1.454), while non-US born Hispanics had the best prognosis (0.74; 0.684–0.804). US born Hispanics (0.86; CI 0.823–0.892) had a significantly better prognosis than Whites (ref.). The Hispanic population appears to have a better prognosis compared to their Caucasian peers while both do better than Blacks across all stages and in local and regional disease subsets. Furthermore, non-US born Hispanics had a better prognosis than US born Hispanics. The cause of this disparity is unclear and warrants further investigation.